A share price of Amneal Pharmaceuticals Inc [AMRX] is currently trading at $6.82, up 2.25%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AMRX shares have gain 7.40% over the last week, with a monthly amount glided 0.15%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Goldman upgraded its rating to Buy on March 08, 2021, and elevated its price target to $6.50. On December 14, 2020, upgrade upgraded it’s rating to Buy but maintained its price target of $5.50 on the stock. Barclays upgraded its rating to a Overweight and increased its price target to $6 on December 14, 2020. Goldman initiated its recommendation with a Sell and recommended $4 as its price target on July 27, 2020. Guggenheim upgraded its rating to Neutral for this stock on May 12, 2020. In a note dated December 12, 2019, Raymond James downgraded an Mkt Perform rating on this stock.
Amneal Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $2.66 and $7.25. Currently, Wall Street analysts expect the stock to reach $7 within the next 12 months. Amneal Pharmaceuticals Inc [NASDAQ: AMRX] shares were valued at $6.82 at the most recent close of the market. An investor can expect a potential return of 2.64% based on the average AMRX price forecast.
Analyzing the AMRX fundamentals
Trailing Twelve Months sales for Amneal Pharmaceuticals Inc [NASDAQ:AMRX] were 2.50B which represents 18.23% growth. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -2.58 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-43.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.76 points at the first support level, and at 6.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.88, and for the 2nd resistance point, it is at 6.94.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Amneal Pharmaceuticals Inc [NASDAQ:AMRX] is 1.65. In addition, the Quick Ratio stands at 0.97 and the Cash Ratio stands at 0.06. Considering the valuation of this stock, the price to sales ratio is 0.84, the price to book ratio is 105.70.
Transactions by insiders
Recent insider trading involved Autor Deborah M., Director, that happened on May 17 ’24 when 23447.0 shares were sold. Director, Autor Deborah M. completed a deal on May 16 ’24 to sell 14553.0 shares. Meanwhile, Executive Vice President BOYER ANDREW S sold 29302.0 shares on Aug 11 ’23.
